Registration of securities issued in business combination transactions

Condensed Statements of Changes in Stockholders??? (Deficit) Equity

v3.22.0.1
Condensed Statements of Changes in Stockholders’ (Deficit) Equity - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Jun. 17, 2020
Net income (loss) (1,000) (1,000)
Balance at Jun. 30, 2020 (1,000) (1,000)
Balance at Jun. 17, 2020
Issuance of Common stock to Sponsor [1],[2] $ 431 24,569 25,000
Issuance of Common stock to Sponsor (in Shares) [1],[2] 4,312,500      
Net income (loss) (1,000) (1,000)
Balance at Dec. 31, 2020 $ 431 24,569 (1,000) 24,000
Balance (in Shares) at Dec. 31, 2020 4,312,500      
Balance at Jun. 30, 2020 (1,000) (1,000)
Sale of 4,312,500 Founder Shares $ 431 24,569 25,000
Sale of 4,312,500 Founder Shares (in Shares) 4,312,500      
Net income (loss)
Balance at Sep. 30, 2020 $ 431 24,569 (1,000) 24,000
Balance (in Shares) at Sep. 30, 2020 4,312,500      
Balance at Dec. 31, 2020 $ 431 24,569 (1,000) 24,000
Balance (in Shares) at Dec. 31, 2020 4,312,500      
Net income (loss)
Balance at Mar. 31, 2021 $ 431 24,569 (1,000) 24,000
Balance (in Shares) at Mar. 31, 2021 4,312,500      
Balance at Dec. 31, 2020 $ 431 24,569 (1,000) 24,000
Balance (in Shares) at Dec. 31, 2020 4,312,500      
Balance at Sep. 30, 2021 $ 431 (11,552,330) (11,551,899)
Balance (in Shares) at Sep. 30, 2021 4,312,500      
Balance at Mar. 31, 2021 $ 431 24,569 (1,000) 24,000
Balance (in Shares) at Mar. 31, 2021 4,312,500      
Net income (loss)
Balance at Jun. 30, 2021 $ 431 24,569 (1,000) 24,000
Balance (in Shares) at Jun. 30, 2021 4,312,500      
Excess of cash received over fair value of private placement warrants 1,076,250 1,076,250
Accretion of common stock to redemption amount (1,100,819) (14,892,403) (15,993,222)
Net income (loss) 3,341,073 3,341,073
Balance at Sep. 30, 2021 $ 431 $ (11,552,330) $ (11,551,899)
Balance (in Shares) at Sep. 30, 2021 4,312,500      
[1] In February 2021, the Company effected a 1.4375-for-1 stock split, resulting in 7,187,500 shares of common stock outstanding. In June 2021, our Sponsor forfeited 2,875,000 founder shares for no consideration resulting in 4,312,500 shares of common stock outstanding (see Notes 5 and 9). All share and per-share amounts have been retroactively restated to reflect the share forfeiture.
[2] Includes up to 562,500 common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5).